Detection of Metallo-beta-lactamase Producers Among Clinical Isolates of Enterobacterales in a Tertiary Care Centre, Nepal
- سال انتشار: 1403
- محل انتشار: دوفصلنامه آزمایشگاه پزشکی مدرن، دوره: 7، شماره: 1
- کد COI اختصاصی: JR_MML-7-1_003
- زبان مقاله: انگلیسی
- تعداد مشاهده: 42
نویسندگان
Department of Microbiology, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal
Department of Microbiology, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal
Department of Microbiology, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal
Department of Microbiology, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal
Department of Microbiology, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal
Department of Microbiology, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal
Department of Microbiology, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal
Department of Microbiology, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal
چکیده
Background and Objective: Increased reports of metallo-beta-lactamase (MBL)-producing isolates of Enterobacterales indicate that there are limited therapeutic options available for the treatment of infections caused by these organisms. To the best of our knowledge, there have been only a limited number of studies on MBL-producing Enterobacterales in Nepal. Therefore, this study was conducted to determine the current distribution of MBL-producing isolates in our setting. Methods: This was a cross-sectional study conducted over a period of six months (from August ۲۰۲۳ to January ۲۰۲۴) at the Department of Microbiology, TU Teaching Hospital, Nepal. A total of ۲۴۳ clinical isolates of Enterobacterales from various clinical specimens were subjected to the Modified Carbapenem Inactivation Method (mCIM) and the EDTA-Modified Carbapenem Inactivation Method (eCIM) for the detection of MBL-producing isolates, according to the standard methodology outlined by the latest Clinical and Laboratory Standards Institute (CLSI) guidelines. Result: A total of ۱۱۱ (۴۵.۷۰%) isolates were identified as potential carbapenemase producers, based on their resistance or intermediate susceptibility to carbapenems (Meropenem and/or Imipenem) and/or resistance to cephalosporin subclass III (Ceftazidime). Among the total isolates of Enterobacterales, ۵۲ (۲۱.۴۰%) were confirmed as carbapenemase producers by the mCIM method, ۴۵ (۱۸.۵۰%) were confirmed as MBL producers by the eCIM method, while the remaining ۷ (۲.۹۰%) were identified as serine-carbapenemase producers. Multidrug resistance (MDR) was observed in ۱۵۱ (۶۲.۱۰%) of the total isolates, and all MBL-producing isolates were also MDR. Conclusion: This study found a higher percentage of MBL-producing Enterobacterales isolates, along with a high prevalence of multidrug resistance. Regular surveillance and stringent infection control policies are essential to minimize the spread of resistant strains.کلیدواژه ها
carbapenemase, eCIM, Enterobacterales, mCIM, MDR, phenotypic detection of MBL.اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.